Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102816825A reveals a novel microbial fermentation route for DHEA from plant sterols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106957878B reveals a novel enzymatic route for 2-phenethyl alcohol using L-phenylalanine. Achieves high conversion without toxic byproducts, offering a reliable supply chain solution.
Patent CN103224972B reveals high-yield enzymatic synthesis. Offers supply chain stability and cost efficiency for pharmaceutical manufacturers seeking reliable amino acid intermediates.
Patent CN112063670A reveals a stable adenylate cyclase method for cAMP production, offering reliable pharmaceutical intermediates supply with significant cost and environmental advantages.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN113512569B details a green enzymatic route for Lopinavir intermediates. Achieve high purity and cost reduction in API manufacturing with our advanced biocatalytic solutions.
Patent CN115820782A reveals a green enzymatic route for 7-dehydrocholesterol intermediates, offering superior purity and yield for Vitamin D3 synthesis.
Novel enzymatic method using L-threonine improves yield and stereoselectivity for Droxidopa production, offering significant cost and supply chain advantages.
Novel enzymatic synthesis route for high-purity chiral alcohol intermediate. Reduces cost and improves safety for pharmaceutical manufacturing supply chains.
Patent CN116121310A reveals a high-efficiency enzymatic route for dexketoprofen, offering superior purity and scalable production for reliable pharmaceutical intermediates suppliers.
Patent CN106191089B accelerates 5-AVA yield via transporter overexpression, offering cost-effective supply chain solutions for global pharmaceutical and chemical manufacturers.
Patent CN105483172B reveals enzymatic cascade reaction for nitrocyclopropanes. Offers green manufacturing and cost reduction for pharmaceutical intermediates supply chains.
Patent CN110714002B discloses a highly efficient nitrilase mutant for synthesizing (S)-3-cyano-5-methylhexanoic acid, offering superior stereoselectivity and solubility for scalable pharmaceutical manufacturing.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Patent CN104059952A details immobilized cell catalysis for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global manufacturers.
Novel enzymatic route for Sacubitril intermediate. High purity, cost-effective, scalable manufacturing for cardiovascular API supply chains.
Patent CN116024187B enables enzymatic synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103820416B reveals high-stereoselectivity ester hydrolase for chiral synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced patent CN110590606A details efficient asymmetric hydrogenation and enzymatic reduction for high-purity pharmaceutical intermediates, ensuring cost-effective and scalable supply chain solutions.
Patent CN1491951A reveals novel asymmetric hydrogenation and microbial routes for high-purity azepine intermediates, offering significant cost reduction in pharmaceutical manufacturing.